麗珠集團(000513.SZ)與健康元簽訂三年持續關聯/連交易框架協議
格隆匯8月16日丨麗珠集團(000513.SZ)公佈,公司根據未來生產經營需要就包括但不限於商品採購等事項與控股股東健康元藥業集團股份有限公司(“健康元”)及其子公司發生關聯/連交易,經合理預測,同時參照以往年度實際發生的持續關聯/連交易情況,公司與健康元簽訂2020年-2022年三年持續關聯/連交易框架協議,框架協議約定2020年、2021年及2022年未來三年雙方發生的持續關聯/連交易總金額分別不超過人民幣4.45億元、4.56億元、4.67億元。具體交易事項在雙方不違背框架協議的基礎上另行簽訂具體實施合同執行。
截止至公告披露日,健康元直接或間接持有公司股權共計44.81%,根據《深圳證券交易所股票上市規則》及《香港聯合交易所有限公司證券上市規則》,健康元為公司的關聯/連人士,此次交易構成了《股票上市規則》和《證券上市規則》項下的關聯/連交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.